logo
#

Latest news with #Nexus'

Nexus Pharmaceuticals Launches Methylene Blue Injection
Nexus Pharmaceuticals Launches Methylene Blue Injection

Yahoo

time22-05-2025

  • Business
  • Yahoo

Nexus Pharmaceuticals Launches Methylene Blue Injection

LINCOLNSHIRE, Ill., May 22, 2025--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood's ability to carry oxygen. "The launch represents a vital addition to Nexus' growing portfolio of life-saving and difficult-to-manufacture medications," said Usman Ahmed, CEO of Nexus Pharmaceuticals. "Methylene Blue is a critical drug in emergency care, and we're proud to contribute to the FDA-approved supply." Nexus' Methylene Blue is available in cartons of five, single-dose 10 mL vials (5 mg/mL) (0.5%). Order through your Wholesaler or from Customer Service at (888) 806-4606. Unit of Sale NDC: 14789-0119-05 - Cencora – 10299117- Cardinal – 5982525- McKesson – 3029428- Morris & Dickson – 609628 About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC, a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they're needed most. View source version on Contacts Media Contact: Grace Conroygconroy@ (847) 527-7490

Nexus Pharmaceuticals Launches Methylene Blue Injection
Nexus Pharmaceuticals Launches Methylene Blue Injection

Business Wire

time22-05-2025

  • Business
  • Business Wire

Nexus Pharmaceuticals Launches Methylene Blue Injection

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood's ability to carry oxygen. 'The launch represents a vital addition to Nexus' growing portfolio of life-saving and difficult-to-manufacture medications,' said Usman Ahmed, CEO of Nexus Pharmaceuticals. 'Methylene Blue is a critical drug in emergency care, and we're proud to contribute to the FDA-approved supply.' Nexus' Methylene Blue is available in cartons of five, single-dose 10 mL vials (5 mg/mL) (0.5%). Order through your Wholesaler or from Customer Service at (888) 806-4606. Unit of Sale NDC: 14789-0119-05 - Cencora – 10299117 - Cardinal – 5982525 - McKesson – 3029428 - Morris & Dickson – 609628 About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC, a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they're needed most.

Historian Yuval Harari warns of paradox of trust behind AI race
Historian Yuval Harari warns of paradox of trust behind AI race

Korea Herald

time20-03-2025

  • Politics
  • Korea Herald

Historian Yuval Harari warns of paradox of trust behind AI race

Author of 'Nexus' discusses threats to democracy, truth and equality As humanity faces unprecedented changes driven by rapid advancements in artificial intelligence, historian and best-selling author Yuval Noah Harari warns of significant potential risks. While humanity has created many impactful tools -- such as knives, the printing press and even atomic bombs -- Harari, known globally for influential books such as 'Sapiens' and 'Homo Deus,' which examine humanity's past and future, stressed that artificial intelligence stands apart, as it's not simply a tool but an autonomous agent capable of independent decision-making and innovation. 'An AI weapon can independently decide whom to bomb, and an AI system can even develop entirely new weapons on its own,' Harari said during a press conference Thursday in Jongro-gu, Seoul. 'The invention of AI represents a completely different kind of revolution compared to all previous technological breakthroughs. Anyone who believes we can control AI just as we controlled previous tools fundamentally misunderstands what AI truly means.' In South Korea to promote his new book, "Nexus: A Brief History of Information Networks from the Stone Age to AI," and to attend a forum hosted by the Ministry of Culture, Sports and Tourism, Harari highlighted the troubling "paradox of trust" surrounding AI. Given AI's profound potential impacts -- characterized by Harari as possibly the greatest transformation in human history -- he stressed the necessity for cautious development, pointing out that technology leaders are struggling with critical trust issues precisely when trust is most essential. There is a growing global crisis of trust among people in which leaders spearheading AI development increasingly distrust each other, yet paradoxically place immense trust in the technology itself. Harari noted that whenever he meets leaders in AI technology, their primary fear is competitors gaining supremacy in the AI race and eventually dominating the world. He explained that this fear arises from the possibility that AI development could lead to disproportionate power concentrated in the hands of just a few countries or corporations, dramatically widening the gap between the technological "haves" and "have-nots" -- a scenario reminiscent of inequalities that emerged during the industrial revolution of the 19th century. He also pointed out the rise of cheap, attractive fiction over costly, complicated truth in the era of information technology. The rise of social media platforms has resulted in a mix of fiction and truth and preference for engagement, even pushing politicians to act for more engagement instead of being responsible and truthful. 'For social media platforms, engagement is important. Engagment is a good measure in the entertainment business but not in the news business,' the author said, stressing that the role of journalism is even more important than ever. When asked about South Korea's political situation, Harari humorously noted his initial confusion when he first learned about it, thinking North Korea had finally experienced a coup. However, he also said he was ultimately unsurprised by South Korea's martial law declaration, amid similar political developments worldwide. 'The biggest problem with democracy is what happens if the person that you give power to doesn't want to give it back. Once they have the power, they can use the power that they gained democratically in order to stay in power,' he said, adding that check and balance mechanisms such as journalism and judicial oversight are essential in democracies. Facing profound changes the direction of which remains uncertain, Harari said people should cultivate a wide range of skills -- intellectual, emotional and physical -- to adapt effectively to the rapidly shifting job market. 'The job market will become extremely volatile, continuously evolving as AI keeps improving,' he explained. 'People will need highly flexible minds, with the ability to keep learning and adapting throughout their entire lives.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store